NT5E and head and neck squamous cell carcinoma: Hence, a biotherapy targeting miR-422a/CD73 may be highly beneficial for patients displaying miR-422aLow/CD73high tumors, to prevent loco-regional recurrence in HNSCC in advanced stages (all locations included).